Other languages Oxford Biomedica plc

Equities

Real-time Estimate Cboe Europe Other stock markets 06:30:02 2024-04-30 am EDT			5-day change	1st Jan Change
265 ^GBX	+1.92%		+23.41%	+20.60%

Apr. 29	FTSE 100 as investors look to Fed rate decision	AN
Apr. 29	Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024

FTSE 100 as investors look to Fed rate decision	Apr. 29
Oxford BioMedica bullish; Petrofac slumps	Apr. 29
Earnings Flash (OXB.L) OXFORD BIOMEDICA Reports FY23 Revenue GBP89.5M	Apr. 29
Oxford Biomedica plc Reiterates Earnings Guidance for the Year 2024	Apr. 29
Oxford Biomedica plc Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 29
HSBC likes Haleon, cuts Flutter to 'hold'	Apr. 18
EARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stake	Mar. 20
Oxford Biomedica Secures New Deal, Expands Existing Agreements for Clinical Programs	Mar. 20
Oxford Biomedica plc Announces Board Changes	Mar. 11
EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract	Mar. 05
Oxford Biomedica plc Provides Earnings Guidance for the Year Ended December 31, 2023 and for the Fiscal Year 2024	Mar. 05
Barclays cuts Bank of Ireland to 'equal weight'	Mar. 05
EnSilica hires new chief financial officer from Oxford Biomedica	Feb. 05
EnSilica Appoints Oxford Biomedica Executive as CFO	Feb. 05
Oxford Biomedica Completes EUR15 Million ABL Europe Acquisition	Jan. 29
Institut Merieux ups stake in Oxford BioMedica toward 10%	Jan. 29
Oxford Biomedica plc completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH ?6.1 million	Jan. 28
Oxford BioMedica posts optimistic outlook on uptick in contract value	Dec. 07
Oxford Biomedica plc Provides Business Update	Dec. 07
Goldman lifts Landsec and British Land	Dec. 05

No results for this search